Ronald A Ghossein

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity
    Jeffrey Liu
    Department of Otolaryngology Head and Neck Surgery, Columbia University, New York, New York, USA
    Cancer 107:1255-64. 2006
  2. ncbi request reprint Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications
    Ronald A Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 17:655-61. 2007
  3. doi request reprint Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression
    Ronald A Ghossein
    Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E1414-21. 2013
  4. pmc Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
    Cherry L Estilo
    Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA
    BMC Cancer 9:11. 2009
  5. doi request reprint Papillary thyroid carcinoma tall cell variant
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 18:1179-81. 2008
  6. ncbi request reprint Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases
    Ronald A Ghossein
    Department of Pathology Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 106:1669-76. 2006
  7. doi request reprint Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Arch Pathol Lab Med 133:683-91. 2009
  8. pmc Update to the College of American Pathologists reporting on thyroid carcinomas
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 10065, New York, NY, USA
    Head Neck Pathol 3:86-93. 2009
  9. doi request reprint Encapsulated malignant follicular cell-derived thyroid tumors
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Endocr Pathol 21:212-8. 2010
  10. ncbi request reprint Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients
    David Hiltzik
    Department of Otolaryngology Head and Neck Surgery, Columbia University, New York, NY, USA
    Cancer 106:1286-95. 2006

Detail Information

Publications50

  1. ncbi request reprint Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity
    Jeffrey Liu
    Department of Otolaryngology Head and Neck Surgery, Columbia University, New York, New York, USA
    Cancer 107:1255-64. 2006
    ..The objective of this study was to assess the behavior of FVPTC, especially its encapsulated form, and shed more light on its true position in the classification scheme of well differentiated thyroid carcinoma...
  2. ncbi request reprint Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications
    Ronald A Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 17:655-61. 2007
    ..To assess the biologic and clinical behavior of TCV without ETE, we performed a detailed comparative clinicopathologic analysis of classical PTC and TCV without ETE...
  3. doi request reprint Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression
    Ronald A Ghossein
    Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E1414-21. 2013
    ..The mutated BRAF V600E protein has been specifically detected in papillary thyroid carcinomas (PTCs) using immunohistochemical (IHC) analysis. The clonal origin of PTCs harboring BRAF mutations has recently been called into question...
  4. pmc Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
    Cherry L Estilo
    Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, NY, USA
    BMC Cancer 9:11. 2009
    ..The present study is aimed at identifying potential candidate genes as prognostic markers in human oral tongue squamous cell carcinoma (SCC) by large scale gene expression profiling...
  5. doi request reprint Papillary thyroid carcinoma tall cell variant
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Thyroid 18:1179-81. 2008
    ..Because there are serious prognostic and management implications to a diagnosis of TCV, we review the entity to inform clinicians about the many facets of TCV...
  6. ncbi request reprint Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases
    Ronald A Ghossein
    Department of Pathology Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 106:1669-76. 2006
    ..Because to the authors' knowledge most studies do not focus exclusively on the encapsulated Hurthle cell carcinoma (EHC), the current study attempted to identify predictors of recurrence in EHC...
  7. doi request reprint Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Arch Pathol Lab Med 133:683-91. 2009
    ..These controversies have an impact on the prognosis and therapy of patients with thyroid carcinoma as well as on the development of robust cutting-edge research aimed at better outcome and quality of life...
  8. pmc Update to the College of American Pathologists reporting on thyroid carcinomas
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 10065, New York, NY, USA
    Head Neck Pathol 3:86-93. 2009
    ..Despite past and recent efforts, there are a number of controversial issues in the classification and diagnosis of thyroid carcinomas (TC) that, potentially impact on therapy and prognosis of patients with TC...
  9. doi request reprint Encapsulated malignant follicular cell-derived thyroid tumors
    Ronald Ghossein
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Endocr Pathol 21:212-8. 2010
    ..If noninvasive, encapsulated FVPTC should be treated in a very conservative fashion. EFC with angioinvasion, especially if extensive, should not be termed minimally invasive in order to prevent undertreatment of the patient...
  10. ncbi request reprint Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients
    David Hiltzik
    Department of Otolaryngology Head and Neck Surgery, Columbia University, New York, NY, USA
    Cancer 106:1286-95. 2006
    ....
  11. doi request reprint Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns
    Michael Rivera
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Mod Pathol 23:1191-200. 2010
    ..The molecular profile of encapsulated and infiltrative follicular variant parallels their biological behavior (ie, metastatic nodal and invasive patterns)...
  12. pmc Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma
    Eric J Sherman
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Thyroid 23:593-9. 2013
    ..In thyroid cancer cell lines, romidepsin increases expression of both thyroglobulin and the sodium iodide symporter messenger RNAs, suggesting the possibility of improved iodine concentrating ability of RAI-resistant tumors...
  13. ncbi request reprint Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity
    Zhenkun Yu
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Mol Ther 15:103-13. 2007
    ..These results suggest that nectin-1 may be used as a marker to predict the sensitivity of a tumor to herpes oncolytic therapy...
  14. ncbi request reprint Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surgery 136:1122-8. 2004
    ....
  15. ncbi request reprint SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma
    Inderpal S Sarkaria
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Thorac Surg 78:1734-41. 2004
    ..We hypothesized that SCCRO expression would correlate with invasive tumor phenotypes and worse survival in BAC...
  16. ncbi request reprint Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity
    Volkert B Wreesmann
    Laboratory of Epithelial Cancer Biology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Genes Chromosomes Cancer 40:355-64. 2004
    ..Our findings suggest a stronger relationship between the FVPTC and FTA/FTC than previously appreciated and support further consideration of the current classification of thyroid neoplasms...
  17. doi request reprint Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study
    Michael Rivera
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Hum Pathol 41:172-80. 2010
    ..EFHG with absent vascular invasion have an excellent prognosis despite the frequent occurrence of tumor necrosis. NRAS mutations are the most frequent oncogenic event in EFHG...
  18. doi request reprint Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 115:2128-37. 2009
    ..The aim of the current study was to determine patterns of failure and adverse prognostic features...
  19. pmc Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
    Mabel Ryder
    Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 296, New York, New York 10021, USA
    Endocr Relat Cancer 15:1069-74. 2008
    ..As novel therapies directed against thyroid tumor cell-specific targets are being tested, the potential role of TAMs as potential modulators of the thyroid cancer behavior will need to be considered...
  20. doi request reprint Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)
    Michael Rivera
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Thyroid 19:119-27. 2009
    ..This study aims to assess the behavior of EPTC according to its growth pattern...
  21. doi request reprint Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience
    Stephanie A Terezakis
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:795-801. 2009
    ..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
  22. ncbi request reprint Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma
    Margo Shoup
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 197:191-7. 2003
    ..This study aims to evaluate outcomes and to define independent variables that are associated with tumor-related mortality in patients with distant metastasis from thyroid carcinoma...
  23. ncbi request reprint Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12
    Richard J Wong
    Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 10:4509-16. 2004
    ..The ability of an interleukin (IL)-12-expressing HSV to treat squamous cell carcinoma (SCC) by inhibition of tumor angiogenesis is investigated in this study...
  24. ncbi request reprint Hürthle cell carcinoma: a 60-year experience
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 9:197-203. 2002
    ..The aim of this study was to define the clinical behavior and prognostic indicators of outcome in Hürthle cell cancer (HCC)...
  25. doi request reprint Micromedullary thyroid cancer: how micro is truly micro?
    Venu G Pillarisetty
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 16:2875-81. 2009
    ..The aggressive nature of medullary thyroid cancer (MTC) is evidenced by its propensity to present early with lymph node (LN) metastases. The clinical significance of sporadic MTC < or =1 cm (micro-MTC) is not clearly defined...
  26. pmc Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1
    Julio C Ricarte-Filho
    Human Oncology and Pathogenesis Program and Departments of Medicine and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer Res 69:4885-93. 2009
    ....
  27. ncbi request reprint Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 34:54-64. 2003
    ..The molecular phenotype, p27(+)Bcl-2(+)Ki-67(-)mdm2(+), appears to be unique to nonmalignant parathyroid tumors, and multimarker phenotypes are more complex in carcinomas...
  28. ncbi request reprint Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 9:789-98. 2002
    ..We identified factors predictive of outcome for recurrent differentiated thyroid carcinoma (DTC)...
  29. ncbi request reprint Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis
    Vivian E Strong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Surgery 143:759-68. 2008
    ..Pheochromocytomas are malignant in approximately 10% of patients. The histologic differentiation between benign and malignant tumors is difficult, the latter diagnosed by the presence of metastatic disease or recurrence...
  30. doi request reprint Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma
    Michael Rivera
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 113:48-56. 2008
    ..However, to the authors' knowledge, the histology of FDG-PET-positive RAIR metastatic thyroid carcinoma has not been described to date...
  31. doi request reprint Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
    Matti L Gild
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Endocr Relat Cancer 20:659-67. 2013
    ..These data establish mTOR as a key mediator of RET-mediated cell growth in thyroid cancer cells and provide a rationale for combinatorial treatments in thyroid cancers with oncogenic RET mutations...
  32. pmc Genome-wide appraisal of thyroid cancer progression
    Volkert B Wreesmann
    Laboratory of Epithelial Cancer Biology, Head and Neck Service, New York, New York 10021, USA
    Am J Pathol 161:1549-56. 2002
    ..Our data suggests that the development of chromosomal instability underlies the progression to more aggressive phenotypes of thyroid cancer and sheds light on the possible genomic aberrations that may be selected for during this process...
  33. ncbi request reprint The role of operations for distantly metastatic well-differentiated thyroid carcinoma
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surgery 131:636-43. 2002
    ..The role of operations for distantly metastatic well-differentiated thyroid carcinoma (DTC) is poorly defined. We review the indications for operation for metastatic DTC...
  34. pmc Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Alan L Ho
    Head and Neck Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA
    N Engl J Med 368:623-32. 2013
    ..In mouse models of thyroid cancer, selective mitogen-activated protein kinase (MAPK) pathway antagonists increase the expression of the sodium-iodide symporter and uptake of iodine. Their effects in humans are not known...
  35. doi request reprint Adrenocortical carcinoma: the influence of large vessel extension
    Harma K Turbendian
    Department of Surgery, New York Presbyterian Hospital Weill Cornell, New York, NY, USA
    Surgery 148:1057-64; discussion 1064. 2010
    ..The impact of large vessel extension (LVE) as a prognostic factor for adrenocortical carcinoma (ACC) is not fully understood. This study aimed to assess outcome of ACC in the presence and absence of LVE...
  36. ncbi request reprint Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:1365-72. 2008
    ..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
  37. pmc Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue
    Neil M Iyengar
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
    Cancer 120:983-91. 2014
    ..Although obesity increases risk and negatively affects survival for many malignancies, the prognostic implications in squamous cell carcinoma (SCC) of the oral tongue, a disease often associated with prediagnosis weight loss, are unknown...
  38. pmc Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease
    Iñigo Landa
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Clin Endocrinol Metab 98:E1562-6. 2013
    ..Telomerase activity is required for cell immortalization. Somatic TERT promoter mutations modifying key transcriptional response elements were recently reported in several cancers, such as melanomas and gliomas...
  39. doi request reprint Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review
    Eric J Sherman
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States
    Radiother Oncol 101:425-30. 2011
    ..We evaluated our more recent experience with this approach, which included pathologic confirmation of all cases...
  40. pmc Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas
    Cristina Montero-Conde
    Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer Discov 3:520-33. 2013
    ..The determinants of primary resistance to MAPK inhibitors vary between cancer types, due to preferential upregulation of specific receptor tyrosine kinases, and the abundance of their respective ligands...
  41. doi request reprint Histologically bland "extremely well differentiated" thyroid carcinomas arising in struma ovarii can recur and metastasize
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Gynecol Pathol 28:222-30. 2009
    ..The hormonal milieu during pregnancy may lead to progression of malignant SO and such patients should be closely followed, particularly if their treatment consists of cystectomy alone...
  42. ncbi request reprint Clinical curiosity: cribriform-morular variant of papillary thyroid carcinoma
    Kimberly M Dalal
    Division of Head and Neck Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Head Neck 28:471-6. 2006
    ..This diagnosis may precede the symptoms of colorectal polyposis...
  43. ncbi request reprint Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12
    Richard J Wong
    Head and Neck Service, Laboratory of Epithelial Cancer Biology, Hepatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 10:251-9. 2004
    ..Engineered herpes oncolytic viruses are effective therapeutic agents when delivered directly to tumors in animal models, but their efficacy in treating disseminated disease is poorly defined...
  44. ncbi request reprint Macrofollicular variant of papillary carcinoma: a potential thyroid FNA pitfall
    Daniel Chung
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Diagn Cytopathol 35:560-4. 2007
    ..The presence of abundant colloid, macrophages, macrofollicular follicular cell arrangement and/or absence of widespread cytologic features associated with papillary carcinoma can lead to an erroneous diagnosis of goiter...
  45. ncbi request reprint Mucoepidermoid carcinoma as a secondary malignancy in pediatric sarcoma
    Daniel N Rutigliano
    Department of Surgery, Division of Pediatric Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Pediatr Surg 42:E9-13. 2007
    ..To our knowledge, this is the first series of mucoepidermoid carcinomas arising in pediatric patients treated for sarcoma without radiotherapy...
  46. ncbi request reprint Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases
    Mona M Sabra
    1 Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell College of Medicine, New York, New York
    Thyroid 24:1088-95. 2014
    ....
  47. ncbi request reprint Adrenocortical carcinoma: clinical, morphologic, and molecular characterization
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:941-50. 2002
    ..To define multimolecular phenotypes of adrenocortical carcinoma (ACC) and to correlate outcome with morphologic and molecular parameters...
  48. ncbi request reprint Ectopic (mediastinal) parathyroid adenoma with prominent lymphocytic infiltration
    Enzo Fallone
    Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Appl Immunohistochem Mol Morphol 17:82-4. 2009
    ..Immunohistochemical studies were important in making such a diagnosis...
  49. doi request reprint Teratocarcinosarcoma of the nasal cavity and paranasal sinuses: report of 3 cases with assessment for chromosome 12p status
    Fadi Salem
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Hum Pathol 39:605-9. 2008
    ..Our findings suggest that 12p amplification, if it occurs at all in this setting, is exceptional and that SNTCS is a somatic-type neoplasm exhibiting divergent differentiation rather than a germ cell tumor...
  50. ncbi request reprint Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas
    Chandrakanth Are
    Division of Surgical Oncology, Department of Surgery, Eppley Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA
    Ann Surg Oncol 14:3210-5. 2007
    ..The aim of our study was to determine if these FDG-PET-detected thyroid malignancies represent a more-aggressive variant of primary thyroid carcinoma...